Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2378]
News [3451]
Articles [283]
Editorials [30]
Conferences [173]
elearning [101]
OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology
Dr Toni Choueiri, Dr Andrea Apolo, Dr Neeraj Agarwal, Dr Piet Ost, Dr Sean...
OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology ( Dr Toni Choueiri, Dr Andrea Apolo, Dr Neeraj Agarwal, Dr Piet Ost, Dr Sean McBride, Dr Ravindran Kanesvaran & Dr Nicolo Battisti )
19 Jan 2022
Evidence-based oncology for trainees from LMICs
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Evidence-based oncology for trainees from LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
14 Jan 2022
The only Journey is the one within
Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
The only Journey is the one within ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
13 Jan 2022
Art and medicine
Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
Art and medicine ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
13 Jan 2022
Empathy in cancer care
Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
Empathy in cancer care ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
13 Jan 2022
Teamwork in cancer care
Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
Teamwork in cancer care ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
13 Jan 2022
Social distancing and economic crisis in Latin America during the COVID-19...
Prof Richard Sullivan and Prof Bettina Müller
Social distancing and economic crisis in Latin America during the COVID-19 pandemic ( Prof Richard Sullivan and Prof Bettina Müller )
10 Jan 2022
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib +...
Dr Komal Jhaveri - Memorial Sloan-Kettering Cancer Center, New York, USA
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + trastuzumab for triple-negative disease ( Dr Komal Jhaveri - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Dec 2021
WHO and St. Jude Children’s research hospital to dramatically increase global...
Dr Andre Llbawi - World Health Organization (WHO) Global Childhood Cancer...
WHO and St. Jude Children’s research hospital to dramatically increase global access to childhood cancer medicine ( Dr Andre Llbawi - World Health Organization (WHO) Global Childhood Cancer Initiative )
17 Dec 2021
The global platform for access to childhood cancer medicines
Dr James Downing - St. Jude Children’s Research Hospital, Memphis, USA
The global platform for access to childhood cancer medicines ( Dr James Downing - St. Jude Children’s Research Hospital, Memphis, USA )
17 Dec 2021
Cancer medicine shortages for children around the world
Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis...
Cancer medicine shortages for children around the world ( Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis, USA )
17 Dec 2021
INTEGRATE study: Treatment pathways, outcomes and resource use in patients with...
Prof Meral Beksac and Prof Roman Hájek
INTEGRATE study: Treatment pathways, outcomes and resource use in patients with multiple myeloma ( Prof Meral Beksac and Prof Roman Hájek )
15 Dec 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation